China Vaccine Makers Plan To Go Global Despite Product-Safety Doubts
This article was originally published in PharmAsia News
Executive Summary
Chinese drug makers intend to enter the global market for vaccines in a major way, building on creation of the world’s first treatment for the 2009 version of the H1N1 influenza virus commonly known as “swine flu.”